Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish earth-2 study

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 1, 2000, Pages 26-35

  García, Felipe ^a   Alonso, Maria M ^b   Romeu, Joan ^c   Knobel, Hernando ^d   Arrizabalaga, Julio ^e   Ferrer, Elena ^f   Dalmau, David ^g   Ruiz, Isabel ^h   Vidal, Francesc ⁱ   Frances, Adela ^j   Segura, Ferran ^k   Gomez Sirvent, Juan L ^b   Cruceta, Anna ^a   Clotet, Bonaventura ^c   Pumarola, Tomás ^a   Gallart, Teresa ^a   O'Brien, William A ^l   Miró, José M ^a   Gatell, José M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e Hospital Nuestra Senora de Aranzazu   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g HOSPITAL MÚTUA DE TERRASSA   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^j Hospital de las Palmas   (Spain)

^k Hospital Pare Tauli   (Spain)

^l University of Texas Medical Branch School of Medicine   (United States)

more..

Author keywords

Double antiretroviral therapy; Immunologic restoration; Triple antiretroviral therapy; Virologic response

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; T LYMPHOCYTE; TONSIL; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0034273820     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200009010-00004     Document Type: Article

References (18)

1. Carpenter CC, Cooper D, Fischi M, et al. Antiretroviral therapy in adults. Updated recommendation of the International AIDS Soci¬ety-USA panel. JAMA 2000;283:381-91.
2. Levy JA. Caution: should we be treating HIV infection early? Lancet 1998;352:982-3.
3. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficien¬cy virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-9.
4. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
5. Eron JJ, Benoit SL, Jemsek J. Treatment with lamivudine, zidovu¬dine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. N Engl J Med 1995;333:1662-9.
6. Bartlett IA, Benoit SL, lohnson VA. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. Ann Intern Med 1996;125:161-72.
7. Autran B, Carcelain G, Li TS, Blanc C, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-16.
8. Division of AIDS. Division of AIDS table for grading severity of adult adverse experiences. Rockville, MD: National Institute of Allergy and Infectious Disease, 1996.
9. Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystro¬phy, hyperlipidemia and diabetes mellitus: a cohort study. Lancet 1999;353:2093-9.
10. Schockmel G, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in Plasma. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:179-83.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
12. Finzi D, Hermankova M, Pierson T, et al. Identification of a res-ervoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278:1295-1300.
13. Montaner JSG, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine and zidovudine for HIV-infected patients. JAMA 1998;279:930-7.
14. Garcia F, Plana M, Vidal C, et al. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS 1999;13:F79-86.
15. Notermans D, lurriaans S, de Wolf F, et al. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treat¬ment with ritonavir, lamivudine and zidovudine. AIDS 1998;12: 167-73.
16. Tenner-Racz K, Stellbrink HJ, Lünzen J, et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cells counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. / Exp Med 1998;187:949-59.
17. Lafeuillade A, Tamalet C, Poggi C, et al. Antiretroviral effect of zidovudine-didanosine combination on blood and lymph nodes. AIDS 1997;11:67-72.
18. Ruiz L, van Lünzen J, Arno A, et al. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the sup¬pression of persistent HIV-1 replication in lymphoid tissue. AIDS 1999;14;l3:Fl-8.